Lightbridge Provides Business Update and Reports Financial Results for the Third Quarter of 2017
Nov 14, 2017 21:05 pm UTC| Business
RESTON, Va., Nov. 14, 2017 -- Lightbridge Corporation (NASDAQ:LTBR), a U.S. nuclear fuel technology company, today provided a business update and reported financial results for the third quarter ended September 30,...
Fluidigm to Participate in the 29th Annual Piper Jaffray Healthcare Conference
Nov 14, 2017 21:05 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Nov. 14, 2017 -- Fluidigm Corporation (NASDAQ:FLDM) today announced that Chris Linthwaite, President and CEO, and Vikram Jog, Chief Financial Officer, will participate in the upcoming 29th...
Trans World Entertainment to Host Third Quarter Results Conference Call
Nov 14, 2017 21:05 pm UTC| Business
ALBANY, N.Y., Nov. 14, 2017 -- Trans World Entertainment Corporation (Nasdaq:TWMC) announced today that it will host a teleconference call for members of the financial community on Tuesday, November 21, 2017 at 10:00 AM...
Achillion Announces Proposed Secondary Offering of Common Stock
Nov 14, 2017 21:03 pm UTC| Business
NEW HAVEN, Conn., Nov. 14, 2017 -- Achillion Pharmaceuticals, Inc. (“Achillion”) (NASDAQ:ACHN) today announced that Johnson Johnson Innovation-JJDC, Inc. (“JJDC”), an existing stockholder of Achillion, intends to offer...
CarGurus Announces Third Quarter 2017 Financial Results
Nov 14, 2017 21:02 pm UTC| Business
Total revenue of $83.0 million, an increase of 56% year-over-yearGAAP operating income of $2.9 million; Non-GAAP operating income of $2.9 millionGAAP net income of $2.4 million; Non-GAAP net income of $2.2 millionAdjusted...
StoneMor Partners L.P. Issues Update on Sales Team Development
Nov 14, 2017 21:02 pm UTC| Business
TREVOSE, Pa., Nov. 14, 2017 -- StoneMor Partners L.P. (NYSE:STON) (“StoneMor” or the “Partnership”) today provided additional data on the ongoing restructuring of its sales force. Total salespeople within the...
Aptevo Therapeutics to Present at the 29th Annual Piper Jaffray Healthcare Conference
Nov 14, 2017 21:02 pm UTC| Business
SEATTLE, Nov. 14, 2017 -- Aptevo Therapeutics Inc. (Nasdaq:APVO), a biotechnology company focused on developing novel oncology and hematology therapeutics, today announced that management will be presenting at the 29th...